8662
J. Am. Chem. Soc. 2001, 123, 8662-8666
Photochemical Generation of Nitric Oxide from
6-Nitrobenzo[a]pyrene
Kiyoshi Fukuhara,* Masaaki Kurihara, and Naoki Miyata*
Contribution from the DiVision of Organic Chemistry, National Institute of Health Sciences,
Setagaya, Tokyo 158-8501, Japan
ReceiVed April 9, 2001
Abstract: Photolabile 6-nitrobenzo[a]pyrene (6-nitroBaP) released nitric oxide (NO) under visible-light
irradiation. The generation of NO and the concomitant formation of the 6-oxyBaP radical were confirmed by
ESR. BaP quinones were also detected as further oxidized products of the 6-oxyBaP radical. No such
photodegradation was observed with other nitrated BaPs, such as 1-nitroBaP and 3-nitroBaP. DNA-strand
breakage, caused by photoexcited 6-nitroBaP, was closely related to its NO-releasing activity. MO calculations
of nitrated BaP suggest that the perpendicular conformation of the nitro substituent to the aromatic ring is
important for the release of NO with light. These findings may be useful for the development of a new type
of NO donor.
Introduction
crises and cardiac failure.7 This has led to the development of
photochemically triggered NO donors, such as metal nitrosyl
compounds8 and some caged nitric oxides.9 The target of NO
donors in bioregulation is endothelial cells, and the released
NO activates guanyl cyclase. However, little work has been done
to develop an NO donor considering cytotoxicity as the major
biological outcome.10 In the present study, we investigated
6-nitrobenzo[a]pyrene (6-nitroBaP) (Figure 1) as a potential NO
donor and showed that it induces DNA strand breaks upon
photoirradiation. Nitrated benzo[a]pyrenes (1-, 3-, 6-nitro and
1,6- and 3,6-dinitro) are synthesized by the nitration of benzo-
[a]pyrene (BaP). Among them, 6-nitrated BaPs such as 1,6- and
3,6-dinitro-BaPs are unstable under visible light. The instability
of these nitrated BaPs is due to the nitro substituent at the
6-position. We report here that 6-nitroBaP released NO under
visible-light irradiation, while no such photodegradation was
observed with other nitrated BaPs, such as 1- and 3-nitroBaPs,
and that DNA strand breakage was closely related to NO-
releasing activity.
In this paper, we characterize a nitroarene that can release
nitric oxide (NO) and efficiently cleave DNA under photoir-
radiation. NO has been considered to be an important biological
messenger that regulates vasodilation and neurotransmission.1
It also has important roles as a mediator of the cytotoxic action
of macrophages toward tumor cells and microbial pathogens,
through the inhibition of mitochondrial enzyme activity and
DNA synthesis.2 Macrophages also use NO as a cytotoxic agent,
which leads to various types of DNA damage.3 It has been
shown that NO can deaminate primary amines of DNA under
aerobic conditions, and that this leads to mutations and DNA
•-
strand breaks.4 NO can also react with O2 produced from
activated macrophages to form peroxynitrate, which is a strong
oxidant and nitrating agent, resulting in the modification of
protein function5 and causing DNA damage.6
Attention has been concentrated on the use of caged NO com-
pounds as potent vasodilators in the management of hypertensive
* To whom correspondence should be addressed.
Results
(1) Moncada, S.; Palmer, R. M.; Higgs, E. A. Pharmacol. ReV. 1991,
43, 109-142.
To assess the formation of NO upon the photoirradiation of
nitroBaPs, an ESR experiment with (MGD)-Fe as the spin trap11
was performed (Figure 2). ESR analysis of 6-nitroBaP photoir-
radiated for 1 min in the presence of MGD-Fe displayed a three-
(2) Stuehr, D. J.; Gross, S. S.; Sakuma, I.; Levi, R.; Nathan, C. F. J.
Exp. Med. 1989, 169, 1011-1020.
(3) Hibbs, J. B., Jr.; Taintor, R. R.; Vavrin, Z. Science 1987, 235, 473-
476.
(4) (a) Wink, D. A.; Kasprzak, K. S.; Maragos, C. M.; Elespru, R. K.;
Misra, M.; Dunams, T. M.; Cebula, T. A.; Koch, W. H.; Andrews, A. W.;
Allen, J. S.; Keefer, L. K. Science 1991, 254, 1001-1003. (b) Nguyen, T.;
Brunson, D.; Crespi, C. L.; Penman, B. W.; Wishnok, J. S.; Tannenbaum,
S. R. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3030-3034.
(5) (a) Haddad, I. Y.; Pataki, G.; Hu, P.; Galliani, C.; Beckman, J. S.;
Matalon, S. J. Clin. InVest. 1994, 94, 2407-2413. (b) Kaur, H.; Halliwell,
B. FEBS Lett. 1994, 350, 9-12. (c) Kooy, N. W.; Royall, J. A.; Ye, Y. Z.;
Kelly, D. R.; Beckman, J. S. Am. J. Respir. Crit. Care Med. 1995, 151,
1250-1254.
(6) (a) King, P. A.; Anderson, V. E.; Edwards, J. O.; Gustafson, G.;
Plumb, R. C.; Suggs, J. W. J. Am. Chem. Soc. 1992, 114, 5430-5432. (b)
Salgo, M. G.; Stone, K.; Squadrito, G. L.; Battista, J. R.; Pryor, W. A.
Biochem. Biophys. Res. Commun. 1995, 210, 1025-1030. (c) Rubio, J.;
Yermilov, V.; Ohshima, H. In The Biology of Nitric Oxide; Moncada, S.,
Stamler, J., Gross, S., Higgs, E. A., Eds.; Portland Press Proceedings:
London, England, 1996; p 34. (d) Tamir, S.; Burney, S.; Tannenbaum, S.
R. Chem. Res. Toxicol. 1996, 9, 821-827.
(7) (a) Bisset, W. I. K.; Burdon, M. G.; Butler, A. R.; Glidewell, C.;
Reglinski, J. J. Chem. Res., Synop. 1981, 299. (b) Clarke, M. J.; Gaul, J.
B. Struct. Bonding 1993, 81, 147-181.
(8) Flitney, F. W.; Megson, I. L.; Flitney, D. E.; Butler, A. R. Br. J.
Pharmacol. 1992, 107, 842-848.
(9) (a) Makings, L. R.; Tsien, R. Y. J. Biol. Chem. 1994, 269, 6282-
6285. (b) Kwon, N. S.; Lee, S. H.; Choi, C. S.; Kho, T.; Lee, H. S. FASEB
J. 1994, 8, 529-533. (c) Singh, R. J.; Hogg, N.; Joseph, J.; Kalyanaraman,
B. FEBS Lett. 1995, 360, 47-51. (d) Namiki, S.; Kaneda, F.; Ikegami, M.;
Arai, T.; Fujimori, K.; Asada, S.; Hama, H.; Kasuya, Y.; Goto, K. Bioorg.
Med. Chem. 1999, 7, 1695-1702.
(10) Hou, Y.; Wang, J.; Andreana, P. R.; Cantauria, G.; Tarasia, S.; Sharp,
L.; Braunschweiger, P. G.; Wang, P. G. Bioorg. Med. Chem. Lett. 1999, 9,
2255-2258.
(11) Komarov, A.; Mattson, D.; Jones, M. M.; Singh, P. K.; Lai, C.-S.
Biochem. Biophys. Res. Commun. 1993, 195, 1191-1198.
10.1021/ja0109038 CCC: $20.00 © 2001 American Chemical Society
Published on Web 08/10/2001